MyFinsight
Home
About
Contact
lctx: the income statement
Download
Download image
Net loss
attributable to lineage
-$29,781K
(-881.58%↓ Y/Y)
Net (income) loss
attributable to...
$29K
(-12.12%↓ Y/Y)
Net loss
-$29,752K
(-891.40%↓ Y/Y)
Royalties License And
Other Revenues
$137K
Collaboration Revenues
$3,544K
Total other income
(expenses)
-$25,966K
(-3194.87%↓ Y/Y)
Loss from operations
-$3,786K
(1.41%↑ Y/Y)
Foreign currency
transaction gain (loss), net
$219K
(-51.12%↓ Y/Y)
Gain (loss) on
marketable equity...
$6K
(200.00%↑ Y/Y)
Interest income, net
$366K
(-7.81%↓ Y/Y)
Total revenues
$3,681K
(-2.59%↓ Y/Y)
Change in fair value of
warrant liability
$26,557K
Total operating
expenses
$7,467K
(-2.00%↓ Y/Y)
General and
administrative
$4,191K
(-4.97%↓ Y/Y)
Research and development
$3,271K
(3.15%↑ Y/Y)
Cost of royalties
$5K
Back
Back
Income Statement
source: myfinsight.com
Lineage Cell Therapeutics, Inc. (LCTX)
Lineage Cell Therapeutics, Inc. (LCTX)